Collection
The Immune System and Cancer\Immunotherapy
- Submission status
- Closed
The connection between the Immune System and Cancer has been always there, but only recently, it has been possible to uncover some vulnerable targets of the system, check-point inhibitors among others, that look very promising in cancer treatment.This new section will be also open to novel, groundbreaking research manuscripts that deal with aspects of this connection.
We are convinced that this new section will bring an added value to the journal and to our readers. From this page, we encourage scientists and clinicians to submit their manuscripts to the Journal Clinical and Translational Oncology.
We hope that our readers share our enthusiasm of this announcement, the great news of adding a Topical Collection to the Journal.
Articles (103 in this collection)
-
-
Dynamic evaluation of neutrophil-to-lymphocyte ratio as prognostic factor in stage III non-small cell lung cancer treated with chemoradiotherapy
Authors (first, second and last of 6)
- V. Palomar-Abril
- T. Soria-Comes
- I. C. M. Maiques
- Content type: Research Article
- Published: 24 May 2020
- Pages: 2333 - 2340
-
Indicators of a pro-tumor immune response are evident at early stages of breast cancer
Authors
- C. Zhang
- R. A. Kurt
- Content type: Review Article
- Published: 14 May 2020
- Pages: 2153 - 2161
-
Targeting Toll-like receptor 4 with CLI-095 (TAK-242) enhances the antimetastatic effect of the estrogen receptor antagonist fulvestrant on non-small cell lung cancer
Authors (first, second and last of 7)
- S. Fan
- Y. Liao
- B. Ai
- Content type: Research Article
- Open Access
- Published: 04 May 2020
- Pages: 2074 - 2086
-
Immunotherapy‑based combinations versus standard first‑line and hypothyroidism risk
Authors
- G. Roviello
- D. Villari
- R. Roudi
- Content type: Correspondence
- Published: 20 April 2020
- Pages: 1664 - 1665
-
Radiation-induced lymphopenia: the main aspects to consider in immunotherapy trials for endometrial and cervical cancer patients
Authors
- K. Holub
- A. Vargas
- A. Biete
- Content type: Research Article
- Published: 13 April 2020
- Pages: 2040 - 2048
-
The role of macrophages during breast cancer development and response to chemotherapy
Authors (first, second and last of 11)
- S. Tao
- Z. Zhao
- Y. Ding
- Content type: Review Article
- Published: 11 April 2020
- Pages: 1938 - 1951
-
Cellular immunotherapy: a clinical state-of-the-art of a new paradigm for cancer treatment
Authors (first, second and last of 4)
- Á. Rodríguez Pérez
- D. Campillo-Davo
- D. Benítez-Ribas
- Content type: Review Article
- Published: 07 April 2020
- Pages: 1923 - 1937
-
Neutrophil-to-lymphocyte ratio and lactate dehydrogenase as biomarkers for urothelial cancer treated with immunotherapy
Authors (first, second and last of 11)
- G. L. Banna
- R. Di Quattro
- U. Basso
- Content type: Brief Research Article
- Published: 30 March 2020
- Pages: 2130 - 2135
-
Baseline neutrophil-to-lymphocyte ratio (NLR) is associated with outcome of patients treated with BRAF inhibitors
Authors (first, second and last of 8)
- E. Cocorocchio
- C. Martinoli
- P. Ferrucci
- Content type: Research Article
- Published: 27 February 2020
- Pages: 1818 - 1824
-
Impact of intestinal dysbiosis-related drugs on the efficacy of immune checkpoint inhibitors in clinical practice
Authors (first, second and last of 16)
- E. Pérez-Ruiz
- J. Jiménez-Castro
- A. Rueda
- Content type: Research Article
- Published: 24 February 2020
- Pages: 1778 - 1785
-
The efficacy and safety of immunotherapy targeting the PD-1 pathway for advanced urothelial carcinoma: a meta-analysis of published clinical trials
Authors (first, second and last of 8)
- F. Zhang
- Z. Liu
- X. Wang
- Content type: Research Article
- Published: 21 February 2020
- Pages: 1750 - 1761
-
Eastern Spanish experience with nivolumab in metastatic renal cell carcinoma
Authors (first, second and last of 21)
- J.-F. M. José
- M. Jose
- G. Vicente
- Content type: Research Article
- Published: 11 February 2020
- Pages: 1517 - 1523
-
Resistin is associated with overall survival in non-small cell lung cancer patients during nivolumab treatment
Authors (first, second and last of 20)
- A. Bonaventura
- F. Grossi
- F. Montecucco
- Content type: Research Article
- Published: 11 February 2020
- Pages: 1603 - 1610
-
Immunotherapy-based combinations versus standard first-line treatment for metastatic clear cell renal cell carcinoma: a systematic review and meta-analysis
Authors (first, second and last of 6)
- Sebastiano Buti
- Fausto Petrelli
- Melissa Bersanelli
- Content type: Brief Research Article
- Published: 19 January 2020
- Pages: 1657 - 1663
-
Impact of antibiotic use and other concomitant medications on the efficacy of immune checkpoint inhibitors in patients with advanced cancer
Authors
- A. Iglesias-Santamaría
- Content type: Research Article
- Published: 09 January 2020
- Pages: 1481 - 1490
-
The efficacy and safety of immune checkpoint inhibitors in non-small cell lung cancer patients of different age groups: a meta-analysis
Authors (first, second and last of 11)
- S.-Y. Zheng
- H.-J. Cui
- X. Jiang
- Content type: Research Article
- Open Access
- Published: 20 November 2019
- Pages: 1146 - 1154
-
Dual-targeted therapeutic strategy combining CSC–DC-based vaccine and cisplatin overcomes chemo-resistance in experimental mice model
Authors (first, second and last of 5)
- N. E. El-Ashmawy
- M. L. Salem
- A. O. Ibrahim
- Content type: Research Article
- Published: 20 November 2019
- Pages: 1155 - 1165
-
Multiple antibodies targeting tumor-specific mutations redirect immune cells to inhibit tumor growth and increase survival in experimental animal models
Authors (first, second and last of 7)
- G. S. Shukla
- S. C. Pero
- D. N. Krag
- Content type: Research Article
- Published: 16 November 2019
- Pages: 1094 - 1104
-
Safety and efficacy of PD-1/PD-L1 blockade in patients with preexisting antinuclear antibodies
Authors (first, second and last of 22)
- T. Sakakida
- T. Ishikawa
- K. Takayama
- Content type: Research Article
- Published: 01 October 2019
- Pages: 919 - 927
-
Treatment options beyond immunotherapy in patients with wild-type lung adenocarcinoma: a Delphi consensus
Authors (first, second and last of 8)
- D. Isla
- J. de Castro
- J. M. Trigo
- Content type: Research Article
- Open Access
- Published: 31 July 2019
- Pages: 759 - 771
-
Efficacy and safety of immune checkpoint inhibitor immunotherapy in elderly cancer patients
Authors (first, second and last of 9)
- B. Fox
- M. de Toro Carmena
- I. Márquez-Rodas
- Content type: Research Article
- Published: 29 June 2019
- Pages: 555 - 562
-
Gr-MDSC-linked asset as a potential immune biomarker in pretreated NSCLC receiving nivolumab as second-line therapy
Authors (first, second and last of 11)
- A. Passaro
- P. Mancuso
- F. Bertolini
- Content type: Research Article
- Published: 28 June 2019
- Pages: 603 - 611
-
Evaluation of axillary lymph node metastasis burden by preoperative ultrasound in early-stage breast cancer with needle biopsy-proven metastasis
Authors (first, second and last of 4)
- X. Wang
- L. Chen
- B. Zhang
- Content type: Research Article
- Published: 18 June 2019
- Pages: 468 - 473
-
ILC3 cells promote the proliferation and invasion of pancreatic cancer cells through IL-22/AKT signaling
Authors (first, second and last of 9)
- X. Xuan
- J. Zhou
- W. Yang
- Content type: Research Article
- Published: 15 June 2019
- Pages: 563 - 575
-
Differences of the immune cell landscape between normal and tumor tissue in human prostate
Authors (first, second and last of 7)
- E. Zhang
- F. Dai
- Y. Qiao
- Content type: Research Article
- Published: 10 May 2019
- Pages: 344 - 350
-
Combined strategies for tumor immunotherapy with nanoparticles
Authors
- K. Savitsky
- X. Yu
- Content type: Review Article
- Published: 04 May 2019
- Pages: 1441 - 1449
-
Unveiling the mechanisms of immune evasion in pancreatic cancer: may it be a systemic inflammation responsible for dismal survival?
Authors
- K. Holub
- C. Conill
- Content type: Research Article
- Published: 19 April 2019
- Pages: 81 - 90
-
Serum immunoinflammation-related protein complexes discriminate between inflammatory bowel disease and colorectal cancer
Authors (first, second and last of 5)
- Y. H. Sun
- J. Li
- J. M. Qian
- Content type: Research Article
- Published: 06 April 2019
- Pages: 1680 - 1686
-
Consensus on the use of immune-related response criteria to evaluate the efficacy of immunotherapy in non-small cell lung cancer
Authors
- M. Provencio
- E. Carcereny
- Á. Artal
- Content type: Research Article
- Published: 22 March 2019
- Pages: 1464 - 1471
-
The detection and clinical significance of peripheral regulatory CD4+CD25hiCD127low T cells in patients with non-small cell lung cancer
Authors (first, second and last of 7)
- J. Qiu
- G. Che
- L. Feng
- Content type: Research Article
- Published: 20 February 2019
- Pages: 1343 - 1347
-
Multiple sclerosis outcomes after cancer immunotherapy
Authors (first, second and last of 5)
- Catherine R. Garcia
- Rani Jayswal
- John L. Villano
- Content type: Research Article
- Published: 20 February 2019
- Pages: 1336 - 1342
-
Relationship between tumor-associated immune infiltrate and p16 staining over clinicopathological features in acral lentiginous melanoma
Authors (first, second and last of 16)
- C. A. Castaneda
- M. Castillo
- J. Abugattas
- Content type: Research Article
- Published: 16 February 2019
- Pages: 1127 - 1134
-
Efficacy of nintedanib and docetaxel in patients with advanced lung adenocarcinoma treated with first-line chemotherapy and second-line immunotherapy in the nintedanib NPU program
Authors (first, second and last of 10)
- J. Corral
- M. Majem
- M P. López Criado
- Content type: Research Article
- Published: 15 February 2019
- Pages: 1270 - 1279
-
Efficacy of nivolumab as checkpoint inhibitor drug on survival rate of patients with relapsed/refractory classical Hodgkin lymphoma: a meta-analysis of prospective clinical study
Authors (first, second and last of 8)
- A. Amraee
- M. R. Evazi
- L. Darvish
- Content type: Research Article
- Published: 09 February 2019
- Pages: 1093 - 1103
-
Time for radioimmunotherapy: an overview to bring improvements in clinical practice
Authors (first, second and last of 12)
- O. Leaman Alcibar
- D. Candini
- M. E. Rodríguez-Ruiz
- Content type: Review Article
- Published: 14 January 2019
- Pages: 992 - 1004
-
The role of immunotherapy in small cell lung cancer
Authors (first, second and last of 4)
- A. Calles
- G. Aguado
- R. Álvarez
- Content type: Review Article
- Published: 12 January 2019
- Pages: 961 - 976
-
Efficacy of rechallenge with BRAF inhibition therapy in patients with advanced BRAFV600 mutant melanoma
Authors
- D. Viñal
- D. Martinez
- E. Espinosa
- Content type: Research Article
- Published: 03 January 2019
- Pages: 1061 - 1066
-
Benefit of ablative versus palliative-only radiotherapy in combination with nivolumab in patients affected by metastatic kidney and lung cancer
Authors (first, second and last of 15)
- I. Desideri
- G. Francolini
- L. Livi
- Content type: Research Article
- Published: 18 December 2018
- Pages: 933 - 938
-
Pretreatment neutrophil/lymphocyte, platelet/lymphocyte, lymphocyte/monocyte, and neutrophil/monocyte ratios and outcome in elderly breast cancer patients
Authors (first, second and last of 6)
- B. Losada
- J. A. Guerra
- S. Del Barco
- Content type: Research Article
- Published: 30 November 2018
- Pages: 855 - 863
-
Defective levels of both circulating dendritic cells and T-regulatory cells correlate with risk of recurrence in cutaneous melanoma
Authors (first, second and last of 8)
- M. Tucci
- L. S. Stucci
- F. Silvestris
- Content type: Research Article
- Published: 23 November 2018
- Pages: 845 - 854
-
Impact of systemic inflammation biomarkers on the survival outcomes of cervical cancer patients
Authors
- K. Holub
- A. Biete
- Content type: Research Article
- Published: 23 November 2018
- Pages: 836 - 844
-
Health-related quality of life analysis in stage III melanoma patients treated with adjuvant dendritic cell therapy
Authors (first, second and last of 14)
- M. Bloemendal
- M. J. A. Rietveld
- K. F. Bol
- Content type: Research Article
- Open Access
- Published: 21 November 2018
- Pages: 774 - 780
-
Cancer immunotherapy of patients with HIV infection
Authors (first, second and last of 5)
- M. Gonzalez-Cao
- J. Martinez-Picado
- A. Meyerhans
- Content type: Review Article
- Published: 17 November 2018
- Pages: 713 - 720
-
The clinicopathological and prognostic value of programmed death-ligand 1 in colorectal cancer: a meta-analysis
Authors (first, second and last of 8)
- X. Ni
- X. Sun
- J. Suo
- Content type: Research Article
- Published: 03 November 2018
- Pages: 674 - 686
-
Programmed cell death protein-1 (PD-1)/programmed death-ligand-1 (PD-L1) axis in hepatocellular carcinoma: prognostic and therapeutic perspectives
Authors (first, second and last of 5)
- T. Mocan
- Z. Sparchez
- D. C. Leucuta
- Content type: Review Article
- Published: 01 November 2018
- Pages: 702 - 712
-
Combination of DC/CIK adoptive T cell immunotherapy with chemotherapy in advanced non-small-cell lung cancer (NSCLC) patients: a prospective patients’ preference-based study (PPPS)
Authors (first, second and last of 13)
- Y. Zhao
- G. Qiao
- H. K. Lyerly
- Content type: Research Article
- Published: 29 October 2018
- Pages: 721 - 728
-
Antigen-loaded dendritic cells triggers a specific cytotoxic T lymphocytes immune response against hepatocellular carcinoma: in vitro study
Authors (first, second and last of 5)
- N. E. El-Ashmawy
- E. A. El-Zamarany
- O. A. El-Feky
- Content type: Research Article
- Published: 27 October 2018
- Pages: 636 - 645
-
Macrophage polarization as a novel weapon in conditioning tumor microenvironment for bladder cancer: can we turn demons into gods?
Authors (first, second and last of 8)
- C. Rubio
- E. Munera-Maravilla
- M. Dueñas
- Content type: Review Article
- Published: 05 October 2018
- Pages: 391 - 403
-
TIPE1 suppresses osteosarcoma tumor growth by regulating macrophage infiltration
Authors (first, second and last of 5)
- P. Chen
- J. Zhou
- Q. Zuo
- Content type: Research Article
- Published: 30 July 2018
- Pages: 334 - 341